Patient reported clinical outcomes and personal perspectives after risk reducing surgery
Kehoe, S.M, Mann, M, Richardson, D.L, Lea, J.S, Miller, D.S, Mauer, C
Published in Gynecologic oncology (01.06.2016)
Published in Gynecologic oncology (01.06.2016)
Get full text
Journal Article
GOG 186H: A randomized phase II evaluation of weekly paclitaxel versus weekly paclitaxel with oncolytic reovirus (Reolysin) in the treatment of recurrent or persistent ovarian, fallopian tube, or primary peritoneal cancer
Cohn, D.E, Sill, M, Walker, J.L, O'Malley, D.M, Nagel, C.I, Rutledge, T, Bradley, W.H, Richardson, D.L, Moxley, K, Aghajanian, C
Published in Gynecologic oncology (01.06.2016)
Published in Gynecologic oncology (01.06.2016)
Get full text
Journal Article
Factors associated with clinical trial screening failures in gynecologic oncology
Paulsen, A, Richardson, D.L, Kehoe, S.M, Miller, D.S, Lea, J.S
Published in Gynecologic oncology (01.06.2014)
Published in Gynecologic oncology (01.06.2014)
Get full text
Journal Article
Impact of circulating tumor cells (CTCs) on overall survival among patients treated with chemotherapy plus bevacizumab for advanced cervical cancer: An NRG Oncology/Gynecologic Oncology Group study
Sill, M, Monk, B.J, Penson, R.T, Lankes, H, Leitao, M.M, Ramondetta, L.M, Van Le, L, Richardson, D.L, Landrum, L.M, DiSilvestro, P.A, Behbakht, K, Ueland, F.R, Michael, H, Birrer, M.J
Published in Gynecologic oncology (01.04.2015)
Published in Gynecologic oncology (01.04.2015)
Get full text
Journal Article
Which factors predict bowel complications in patients with recurrent epithelial ovarian cancer being treated with bevacizumab?
Richardson, D.L, Backes, F.J, Hurt, J.D, Seamon, L.G, Copeland, L.J, Fowler, J.M, Cohn, D.E, O'Malley, D.M
Published in Gynecologic oncology (01.07.2010)
Published in Gynecologic oncology (01.07.2010)
Get full text
Journal Article
Sustained progression-free survival with weekly paclitaxel and bevacizumab in recurrent ovarian cancer
Hurt, J.D, Richardson, D.L, Seamon, L.G, Fowler, J.F, Copeland, L.J, Cohn, D.E, Eisenhauer, E, Salani, R, O'Malley, D.M
Published in Gynecologic oncology (01.12.2009)
Published in Gynecologic oncology (01.12.2009)
Get full text
Journal Article
Predictive value of carcinoembryonic antigen and cancer antigen 125 in identifying mucinous ovarian tumors
Manders, D.B, Purinton, S.C, Lea, J.S, Richardson, D.L, Miller, D.S, Kehoe, S.M
Published in Gynecologic oncology (01.11.2011)
Published in Gynecologic oncology (01.11.2011)
Get full text
Journal Article
Outcomes of third line chemotherapy for recurrent and persistent cervical cancer
Manders, D.B, Purinton, S.C, Lea, J.S, Miller, D.S, Kehoe, S.M, Richardson, D.L
Published in Gynecologic oncology (01.11.2011)
Published in Gynecologic oncology (01.11.2011)
Get full text
Journal Article
Light manipulation using organic semiconducting materials for enhanced photosynthesis
Zorz, Jackie, Richardson, William D.L., Laventure, Audrey, Haines, Marianne, Cieplechowicz, Edward, Aslani, Alireza, Vadlamani, Agasteswar, Bergerson, Joule, Welch, Gregory C., Strous, Marc
Published in Cell reports physical science (21.04.2021)
Published in Cell reports physical science (21.04.2021)
Get full text
Journal Article
439TiP AVZO-021-1001: A first-in-human open-label, multicenter phase I/II dose-escalation and expansion study evaluating AVZO-021 in adult patients with advanced solid tumors
Dowlati, A., Richardson, D.L., Lorusso, P., Spira, A.I., Bashir, B., Hirmand, M., Mehta, M., Patel, M.R.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
Combination Gemcitabine and Cisplatin for Recurrent Ovarian Cancer
Richardson, D.L, Kim, K, Seamon, L.G, Cohn, D.E, O'Malley, D.M, Eaton, L.A, Copeland, L.J, Fowler, J.M
Published in Gynecologic oncology (01.11.2007)
Published in Gynecologic oncology (01.11.2007)
Get full text
Journal Article
Comparison of Image-Guided Intensity Modulated Radiotherapy (IG-IMRT) vs. Conventional Radiotherapy (4FRT) for Locoregionally Advanced Cervical Cancer on the NRG GY006 Trial
Mell, L.K., Deng, W., Gao, L., Kunos, C.M., Chino, J.P., Quick, A.M., Feddock, J.M., Donnelly, E.D., Albuquerque, K.V., Leif, J.L., Richardson, D.L., Amarnath, S.R., Jegadeesh, N., Santos-Reyes, L.J., MacKay, H., Aghajanian, C., Monk, B.J., Miller, A., Mayadev, J.S., Leath, C.
Published in International journal of radiation oncology, biology, physics (01.10.2024)
Published in International journal of radiation oncology, biology, physics (01.10.2024)
Get full text
Journal Article
691TiP PYNNACLE phase II trial of rezatapopt (PC14586) in solid tumors with a TP53 Y220C mutation
Schram, A.M., Lopes, G., El-Khoueiry, A.B., Fontana, E., Karasic, T.B., Kummar, S., Lorusso, P., Gregorc, V., Millward, M., Ponce Aix, S., Richardson, D.L., Roda Perez, D., Spira, A.I., Tan, D.S., Thompson, J.A., Uprety, D., Fellous, M., Qin, Y.G., Dumbrava, E.E.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
719MO A phase I/II study of rinatabart sesutecan (Rina-S) in patients with advanced ovarian or endometrial cancer
Lee, E.K., Yeku, O., Winer, I., Hamilton, E.P., Richardson, D.L., Zhang, J., Konecny, G.E., Anderson, I.C., Wu, X., Orr, D., Patel, S., Jewell, A., Wang, J., Spira, A.I., Melnyk, A., Seamon, L., Kavalerchik, E., Chen, Z., Song, E., Call, J.A.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
921P HB-200 arenavirus-based immunotherapy plus pembrolizumab as a first-line treatment of patients with recurrent/metastatic HPV16 positive head and neck cancer
Nabell, L., Ho, A.L., Posner, M.R., Neupane, P., Naqash, A-R., Wong, S., Niu, J.J., Pearson, A.T., Laux, D., Adkins, D.R., Pimentel, A., Rosenberg, A.J., Richardson, D.L., Wong, W., Kaufmann, T.A., Katchar, K., Qing, X., Iacobucci, C., Schlienger, K., Pfister, D.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
A phase IB trial of paclitaxel and carboplatin + galunisertib in patients with uterine and ovarian carcinosarcoma
Gunderson, C.C., Walker, J.L., Mannel, R.S., Holman, L.L., Richardson, D.L., Ding, K., Moxley, K., Landrum, L.M., Rowland, M., Moore, K.N.
Published in Gynecologic oncology (01.10.2020)
Published in Gynecologic oncology (01.10.2020)
Get full text
Journal Article
732P Durvalumab + carboplatin/paclitaxel (CP) followed by durvalumab ± olaparib as a first-line treatment for endometrial cancer (EC): Progression-free survival (PFS) by clinical factors in DUO-E
Blank, S.V., McCollum, M., Anderson, C., Pennington, K., Salinas, E., Richardson, D.L., Slomovitz, B.M., Kim, B-G., Liu, J., Mori, M., Guette, P.L. Ramos, Joseph de Pádua, C., Martinez-Garcia, J., Papadimitriou, C., Grisan, K., Póka, R.L., Kowgier, M., Del Rosario, P.M.D., Van Nieuwenhuysen, E., Westin, S.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
833P Mirvetuximab soravtansine (MIRV), a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with carboplatin (CARBO) and bevacizumab (BEV): Final results from a study in patients (pts) with recurrent platinum sensitive ovarian cancer
O'Malley, D.M., Richardson, D.L., Vergote, I.B., Gilbert, L., Castro, C., Provencher, D., Matulonis, U.A., Mantia-Smaldone, G., Martin, L., Zweidler-Mckay, P.A., Moore, K.N.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article